K-herb Research Center, Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, Republic of Korea; Department of Life Systems, Sookmyung Women's University, Cheongpa-ro 47-gil 100, Yongsan-gu, Seoul 04310, Republic of Korea.
K-herb Research Center, Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, Republic of Korea.
J Ethnopharmacol. 2018 Jan 30;211:78-88. doi: 10.1016/j.jep.2017.09.006. Epub 2017 Sep 15.
The root of Peucedanum japonicum Thunberg is traditionally used to treat coughs, colds, headache and inflammatory diseases in Korea and Japan. Its effects on allergic lung inflammation have not been investigated.
To investigate the anti-asthmatic effects of Peucedanum japonicum extract (PJE) using a murine model of asthma and a lipopolysaccharide (LPS)-stimulated macrophage cell line.
Mice underwent two rounds of sensitization with ovalbumin 1 week apart followed by four intranasal ovalbumin challenges on days 13-16. The control group received saline only. Two ovalbumin-sensitized groups were orally administered vehicle or PJE (200mg/kg) 5 days a week starting 1 week before the first ovalbumin sensitization. The third group was orally administered the asthma medication Montelukast (10mg/kg) on days 12-16. All animals were sacrificed on day 17. The lungs were assessed for histological features, inflammatory cell infiltration, Th2 cell activation and GATA-binding protein-3 (GATA-3) expression. The bronchoalveolar lavage fluid (BALF) was assessed for type 2 cytokine levels. The effect of PJE on the in vitro Th2 polarization of naïve CD4 splenocytes and the production of pro-inflammatory mediators and cytokines by LPS-stimulated RAW 264.7 cells was evaluated.
PJE treatment inhibited OVA-induced inflammatory cell infiltration, eosinophilia, Th2 activation, and GATA-3 expression in the lung, reduced the interleukin (IL)-5 and IL-13 levels in BALF, down-regulated Th2 activation in vitro, and inhibited the macrophage production of inducible nitric oxide, cyclooxygenase-2, tumor necrosis factor-α, and IL-6.
PJE attenuated allergic airway inflammation by inhibiting Th2 cell activation and macrophage production of inflammatory mediators. Peucedanum japonicum may be candidate therapy for allergic lung inflammation.
在韩国和日本,Peucedanum japonicum Thunberg 的根被传统上用于治疗咳嗽、感冒、头痛和炎症性疾病。其对过敏性肺炎症的作用尚未得到研究。
使用哮喘小鼠模型和脂多糖 (LPS) 刺激的巨噬细胞系研究 Peucedanum japonicum 提取物 (PJE) 的抗哮喘作用。
小鼠进行了两轮卵清蛋白致敏,间隔 1 周,然后在第 13-16 天进行 4 次鼻内卵清蛋白挑战。对照组仅接受生理盐水。两组卵清蛋白致敏组在第一次卵清蛋白致敏前 1 周开始每周 5 天口服载体或 PJE(200mg/kg)。第三组在第 12-16 天口服哮喘药物孟鲁司特(10mg/kg)。所有动物均在第 17 天处死。评估肺的组织学特征、炎症细胞浸润、Th2 细胞活化和 GATA 结合蛋白-3 (GATA-3) 表达。评估支气管肺泡灌洗液 (BALF) 中 2 型细胞因子水平。评估 PJE 对体外幼稚 CD4 脾细胞 Th2 极化和 LPS 刺激的 RAW 264.7 细胞产生促炎介质和细胞因子的影响。
PJE 治疗抑制了 OVA 诱导的炎症细胞浸润、嗜酸性粒细胞增多、肺 Th2 活化和 GATA-3 表达,降低了 BALF 中的白细胞介素 (IL)-5 和 IL-13 水平,体外下调了 Th2 活化,并抑制了巨噬细胞产生诱导型一氧化氮、环加氧酶-2、肿瘤坏死因子-α和 IL-6。
PJE 通过抑制 Th2 细胞活化和巨噬细胞产生炎症介质来减轻过敏性气道炎症。Peucedanum japonicum 可能是治疗过敏性肺炎症的候选药物。